Skip to main content
. 2014 Sep 19;78(4):847–854. doi: 10.1111/bcp.12407

Figure 3.

Figure 3

Evaluation of the final model: comparison between confidence interval of the 5th, 50th and 95th simulated percentiles (areas) and the observed 5th, 50th and 95th percentiles (lines); filled circles correspond to the observed data for lamivudine concentrations for twice daily (A) and once daily dosing regimen (B)